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Comparison of health literacy profile of patients with end-stage kidney disease 
on dialysis versus non-dialysis chronic kidney disease and the influencing 
factors: a cross-sectional study 
Abstract 
Objectives: Lower health literacy (HL) is associated with poor outcomes in patients with kidney disease. 
Since HL matches the patient's competencies with the complexities of the care package, the level of HL 
sufficient in earlier stages of chronic kidney disease (CKD) may be inadequate for patients with end-stage 
kidney disease (ESKD) on dialysis. We aimed to analyse the HL profile of patients with ESKD and non-
dialysis CKD and examine if there were significant associations with covariates which could be targeted 
to address HL deficits, thereby improving patient outcomes. Design and setting: Cross-sectional study of 
patients with CKD and ESKD from a single Australian health district. Methods: We assessed the HL profile 
of 114 patients with CKD and 109 patients with ESKD using a 44-item multidomain Health Literacy 
Questionnaire (HLQ) and examined its association with demographic factors (age, gender, race), smoking, 
income, education, comorbidities, carer status, cognitive function and depression. Using multivariable 
logistic regression models, HL profiles of patients with CKD and ESKD were evaluated after adjusting for 
covariates. Results: Patients with ESKD had similar demographics and educational levels compared with 
patients with CKD. ESKD had significantly higher frequency of vascular disease, cognitive impairment and 
depression. Patients with ESKD had better HL scores for the social support domain (37.1% vs 19.5% in 
higher HLQ4 tertile, p=0.004), whereas all other HL domains including engagement with healthcare 
providers were comparable to CKD. Depression was independently associated with nearly all of the HL 
domains (HLQ1: OR 2.6, p=0.030; HLQ2: OR 7.9, p=<0.001; HLQ3: OR 7.6, p<0.001; HLQ4: OR 3.5, p=0.010; 
HLQ5: OR 8.9, p=0.001; HLQ6: OR 3.9, p=0.002; HLQ7: OR 4.8, p=0.001; HLQ8: OR 5.3, p=0.001) and 
education with HL domains relevant to processing health-related information (HLQ8: OR 2.6, p=0.008; 
HLQ9: OR 2.5, p=0.006). Conclusions: Despite very frequent interactions with health systems, patients 
with ESKD on dialysis did not have higher HL in engagement with health providers and most other HL 
domains, compared with patients with CKD. Strategies promoting patient-provider engagement and 
managing depression which strongly associates with lower HL may address the impact of HL deficits and 
favourably modify clinical outcomes in renal patients. 
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ABSTRACT
Objectives Lower health literacy (HL) is associated with 
poor outcomes in patients with kidney disease. Since HL 
matches the patient’s competencies with the complexities 
of the care package, the level of HL sufficient in earlier 
stages of chronic kidney disease (CKD) may be inadequate 
for patients with end- stage kidney disease (ESKD) on 
dialysis. We aimed to analyse the HL profile of patients 
with ESKD and non- dialysis CKD and examine if there 
were significant associations with covariates which could 
be targeted to address HL deficits, thereby improving 
patient outcomes.
Design and setting Cross- sectional study of patients with 
CKD and ESKD from a single Australian health district.
Methods We assessed the HL profile of 114 patients 
with CKD and 109 patients with ESKD using a 44- item 
multidomain Health Literacy Questionnaire (HLQ) and 
examined its association with demographic factors (age, 
gender, race), smoking, income, education, comorbidities, 
carer status, cognitive function and depression. Using 
multivariable logistic regression models, HL profiles 
of patients with CKD and ESKD were evaluated after 
adjusting for covariates.
Results Patients with ESKD had similar demographics 
and educational levels compared with patients with CKD. 
ESKD had significantly higher frequency of vascular 
disease, cognitive impairment and depression. Patients 
with ESKD had better HL scores for the social support 
domain (37.1% vs 19.5% in higher HLQ4 tertile, p=0.004), 
whereas all other HL domains including engagement 
with healthcare providers were comparable to CKD. 
Depression was independently associated with nearly all 
of the HL domains (HLQ1: OR 2.6, p=0.030; HLQ2: OR 
7.9, p=<0.001; HLQ3: OR 7.6, p<0.001; HLQ4: OR 3.5, 
p=0.010; HLQ5: OR 8.9, p=0.001; HLQ6: OR 3.9, p=0.002; 
HLQ7: OR 4.8, p=0.001; HLQ8: OR 5.3, p=0.001) and 
education with HL domains relevant to processing health- 
related information (HLQ8: OR 2.6, p=0.008; HLQ9: OR 2.5, 
p=0.006).
Conclusions Despite very frequent interactions with 
health systems, patients with ESKD on dialysis did not 
have higher HL in engagement with health providers and 
most other HL domains, compared with patients with CKD. 
Strategies promoting patient–provider engagement and 
managing depression which strongly associates with lower 
HL may address the impact of HL deficits and favourably 
modify clinical outcomes in renal patients.
INTRODUCTION
According to the WHO, health literacy 
(HL) denotes the knowledge, motivation 
and competence to access, understand, 
appraise and apply health information, 
which enables patients to make decisions 
to maintain or improve their health and 
quality of life.1 2 Limited HL can impede a 
patient’s ability to interact effectively with 
health providers, health systems and social 
networks, thereby negatively impacting on 
their health outcomes.3 In patients with 
chronic kidney disease (CKD), limited HL 
has been associated with poor medication 
adherence, increased rates of hospital admis-
sions, morbidity and mortality4 5 while among 
Strengths and limitations of this study
 ► Our study provides a direct comparison of health 
literacy profile of patients with end- stage kidney 
disease (ESKD) on dialysis and non- dialysis chronic 
kidney disease (CKD).
 ► We used a health literacy instrument with different 
domains that have independent construct validity 
and reliability and are directly relevant to the inter-
action of the patient with health systems and care 
pathways.
 ► We used multivariable logistic regression to study 
the independent effect of ESKD/CKD status and rel-
evant covariates on health literacy.
 ► The external validity of our results would have im-
proved if our sample size was larger and drawn from 
multiple geographical locations.
 ► The reliability of our findings may have been affected 
by the sensitivity and specificity of the instruments 
used to measure health literacy and covariates like 
cognitive function and depression.
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patients with end- stage kidney disease (ESKD) receiving 
dialysis, limited HL also contributes to missed dialysis 
treatments.5 6
Adequate HL enables patients to navigate the complex 
treatment pathways of kidney diseases including ESKD, 
which are characterised by a heavy pill burden and the 
need to adhere to rigorous fluid and dietary restrictions.7 
The interactive HL framework envisions HL, as a relational 
concept that matches the skills and abilities of the patient 
with the demands and complexity of the care package.1 
Complexity and burden of disease as well as its treatment 
including diet, fluid, pharmacotherapy and self- care chal-
lenges are worse in ESKD compared with CKD. It could 
be argued, therefore, that the same level of HL sufficient 
to self- manage earlier stages of CKD may not be adequate 
to self- manage the more complex treatment challenges 
experienced by patients with ESKD. It could also be 
hypothesised that the frequent and regular interactions 
with the health systems and care providers inherent to 
dialysis therapy for patients with ESKD have the poten-
tial to enhance their HL with respect to patient–provider 
engagement compared with patients with CKD. However, 
a meta- analysis evaluating the HL in renal patients found 
similar prevalence of limited HL among dialysis patients 
and patients with non- dialysis CKD.8 Most of the studies 
included in this meta- analysis used validated HL tools 
which assessed the patient’s proficiency in health- related 
vocabulary, rather than capturing the full scope of HL 
constructs pertinent to chronic disease management. 
The validated multidomain Health Literacy Question-
naire (HLQ) has been developed to evaluate several HL 
domains which are directly relevant to the patient’s inter-
action with health systems and delivery of care.9 10 A study 
which used the HLQ reported that dialysis patients have 
better HL in the domains of social support and engage-
ment with healthcare providers,11 when compared with a 
general patient population. A direct comparison between 
patients with ESKD and CKD may help delineate the HL 
patterns and the impact of influencing factors in renal 
patients.
Based on the gaps in the evidence, we aimed to directly 
compare the HL profile of patients with ESKD under-
going dialysis with patients with non- dialysis CKD after 
adjusting for covariates, which included demographic 
factors, educational level, income, comorbidities, cogni-
tive function and depression. A secondary aim of this 
study was to examine the independent association of HL 
with these covariates in patients with CKD and ESKD, in 
order to identify targets for intervention to address their 
HL deficits which may improve their health outcomes.
METHODS
Patients attending the renal outpatient clinics for treat-
ment of CKD and those undergoing in- centre or home 
dialysis for ESKD, registered in three nephrology units, 
within an Australian local health district were invited 
to participate in this cross- sectional study. We aimed to 
recruit approximately equal numbers of patients with 
non- dialysis CKD and ESKD undergoing dialysis. Patients 
were eligible for inclusion if they were 18 years or older, 
had kidney disease and were able to provide informed 
consent. Patients were excluded if they had undergone 
kidney transplantation or were being actively worked up 
for a living donor transplant; had been diagnosed with 
dementia or an intellectual impairment; had an antic-
ipated life expectancy of less than 12 months based on 
the primary nephrologist’s assessment; or were on a renal 
palliative care pathway. In addition, since the test instru-
ments were administered in English, patients who did not 
speak and read English were excluded.
Patient and public involvement
Patients or members of the public were not involved in 
the design, conduct, reporting or dissemination plans 
of this study as it is not appropriate for the proposed 
research methods.
Data collection
Each participant provided informed consent prior to any 
study procedure. Between January 2015 and June 2016, 
using a combination of interviewing the participants 
and reviewing their medical records, we collected demo-
graphic data (eg, age, gender, race, educational level 
and income), information regarding smoking and carer 
status, as well as clinical data such as cause of renal disease, 
comorbidities, duration of dialysis in patients with ESKD, 
serum creatinine and estimated glomerular filtration rate 
(eGFR) at study enrolment in patients with CKD.
HL was assessed using the 44- item HLQ, which compre-
hensively assesses the patient’s HL skills in different 
domains.10 This instrument assigns four to six test items 
each to nine independent scales, each scale representing 
a unique domain of the overall HL construct, each of 
which has distinct construct validity and reliability.12 The 
scores in each scale are based on the responses to test 
items in a rating scale with four levels (‘strongly disagree’, 
‘disagree’, ‘agree’ or ‘strongly agree’—for scales 1–5) 
or five levels (‘cannot do’, ‘very difficult’, ‘quite diffi-
cult’, ‘quite easy’ or ‘very easy’—for scales 6–9). These 
scales representing the domains include ‘feeling under-
stood and supported by healthcare providers’ (HLQ1), 
‘having sufficient information to manage my health’ 
(HLQ2), ‘actively managing my health’ (HLQ3), ‘social 
support for health’ (HLQ4), ‘appraisal of health infor-
mation’ (HLQ5), ‘ability to actively engage with health-
care providers’ (HLQ6), ‘navigating the healthcare 
system’ (HLQ7), ‘ability to find good health informa-
tion’ (HLQ8) and ‘understand health information well 
enough to know what to do’ (HLQ9).10 The psychometric 
properties of the HLQ have been validated in diverse 
community settings and all HLQ scales were found to be 
homogeneous with composite reliability ranging from 
0.80 to 0.89, in measuring the relatively narrow and 
distinct constructs.9
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The modified Mini- Mental State Examination (3MS 
test) was used to assess cognitive function.13 The test 
assesses a number of domains including memory and 
fluency, executive function, orientation, visuoconstruc-
tion as well as language praxis. The 3MS test has greater 
sensitivity, specificity, receiver operating characteristics 
and test–retest reliability than the MMSE.14 Patients 
were categorised as ‘cognitively impaired’ if their 3MS 
score was below 85%. The trail- making test (difference 
between part B and part A) was used to evaluate exec-
utive function,15 and an interference measure from the 
Stroop task with the colour word test16 was used to assess 
for cognitive control and flexibility. The Beck Depression 
Inventory 2 (BDI-2) was used to assess depression, and 
a cut- off score of ≥14 was used to categorise participants 
as ‘depressed’.17 This instrument, which has been trans-
lated to 17 languages, has a high degree of reliability with 
internal consistency around 0.9 and test–retest reliability 
ranging from 0.73 to 0.96, with broad applicability for 
research and clinical practice.18
The 3MS test, trail- making test and Stroop task were 
administered face to face with the study participants by 
the research nurse. Paper- based copies of the HLQ and 
BDI-2 questionnaires were handed over to the study 
participants for completion and return to the research 
nurse. For patients with ESKD receiving in- centre haemo-
dialysis, test instruments were administered either before 
or in the first hour of dialysis to avoid any possible fluctu-
ations in cognitive function related to the dialysis process. 
To avoid patient fatigue, these test instruments were 
administered in a staggered fashion over consecutive dial-
ysis sessions at the discretion of the research nurse. When 
the HLQ and BDI-2 questionnaires were returned, the 
research nurse reviewed their responses and prompted 
patients to rectify incomplete responses. For patients with 
non- dialysis CKD, or patients with ESKD receiving home- 
based dialysis, who attended the outpatient nephrology 
clinics, all the test instruments and questionnaires were 
completed in a single session to minimise the need for 
revisits to the clinics.
Data analysis
We described baseline characteristics using propor-
tions for discrete variables, and median with IQR for 
continuous variables. The baseline characteristics were 
compared between patients with ESKD and CKD using 
χ2 test for categorical covariates, and non- parametric 
Wilcoxon rank- sum (Mann- Whitney) test for continuous 
variables. Cohen’s d effect size was used to describe the 
difference between mean scores of HLQ scales between 
the ESKD and CKD population.19
To evaluate the association of individual HL domains 
and covariates, we used the categories of higher versus 
lower HL as the dependent variable in logistic regression 
models. Since there are no widely agreed threshold HLQ 
scores to classify patients to the ‘higher’ or ‘lower’ HL 
categories, we divided the population to tertiles for each 
HL scale and compared the highest versus the lower two 
tertiles of scores in each HL scale, because tertiles provide 
a natural order within each domain.
Using a univariate logistic regression model, we exam-
ined the effect of independent covariates such as demo-
graphic factors including age, gender, indigenous status, 
education, annual income, carer status, diabetes, depres-
sion and cognitive function as well as patient subgroup 
(CKD vs ESKD) on the dependent variable of HL cate-
gories based on tertiles. To minimise bias due to the 
confounding effect of covariates, we included all covari-
ates that were associated with any of the HLQ scale cate-
gories at a significance level of p<0.2 as independent 
variables, in a multivariable logistic regression model, 
to ascertain their independent association with each HL 
domain. We also included the ESKD versus CKD status 
as an independent variable in the model to identify any 
significant difference in the HL profile between patients 
with ESKD and CKD after adjusting for covariates. Missing 
data were handled by listwise deletion. Statistical signifi-
cance was set at a two- tailed p value <0.05. All the statis-
tical analyses were undertaken using Stata V.16.0.
RESULTS
Study population
Of the 321 potentially eligible patients (148 ESKD and 
173 CKD) invited to participate in the study, 66 (20.6%) 
declined. Five patients were excluded because they did 
not comply with the inclusion criteria outlined in the 
Methods section and 27 patients dropped out due to 
withdrawal of consent, kidney transplantation or death 
before completing baseline data. The final study cohort 
comprised 223 patients, 109 with ESKD undergoing dial-
ysis (96 in- centre haemodialysis, 7 peritoneal dialysis, 6 
home haemodialysis) and 114 with CKD not receiving 
dialysis. Figure 1 provides the flow diagram of patient 
recruitment in the study.
Baseline characteristics
Table 1 provides the baseline demographic and clinical 
characteristics of the overall study sample and the two 
subgroups.
The median age of the population was 69.6 years with 
the patients with ESKD tending to be younger than the 
patients with CKD (68.0 years vs 71.0 years). The majority 
of the patients with ESKD (62%) and CKD (61%) were 
male. Patients with ESKD had significantly lower annual 
incomes (p=0.001), and more likely to be supported by 
a personal carer (p<0.001). Patients with ESKD had a 
higher prevalence of ischaemic heart disease (p<0.001) 
and peripheral vascular disease (p<0.001). Educational 
level, smoking status, aetiology of renal disease, presence 
of diabetes, hypertension, cerebrovascular disease and 
lung disease were comparable between the ESKD and 
CKD population. The median creatinine was 132 μmol/L 
(IQR 97–171 μmol/L) and median eGFR was 41 mL/min 
(IQR 27–57 mL/min) in the patients with CKD at study 
enrolment.
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Table 2 shows the cognitive and psychological measures 
in the study sample. Cognitive function assessed by 3MS 
test scores (p=0.001) or as the categorical variable of 
‘cognitive impairment’ (p=0.033) was significantly worse 
in patients with ESKD compared with patients with CKD. 
Cerebral executive function assessed by the difference of 
part A and part B of the trail- making test was significantly 
(p<0.001) impaired in patients with ESKD, while the 
Stroop interference score was not significantly (p=0.055) 
different between the two groups of patients. Patients 
with ESKD had a significantly higher frequency of depres-
sion compared with patients with CKD (p<0.001).
The HLQ scores for the patients with ESKD and CKD, 
provided in tables 3 and 4, highlight that there was no 
significant difference between the groups, with respect to 
the mean scores in any of the nine HLQ domains. The 
Cohen’s d showed a small effect size at 0.26 (<0.5, >0.2) for 
patients with ESKD in the HLQ2 domain (‘have sufficient 
information to manage health’). Comparisons based on 
the higher versus lower two tertiles of HLQ scores showed 
a significantly higher proportion of patients with ESKD in 
the higher tertile for the ‘social support domain’ (HLQ4) 
compared with the patients with CKD (37.1% vs 19.5%). 
The remaining eight HL domains showed no significant 
differences.
Association of covariates with HL domains
The univariate association of the covariates and the cate-
gories of higher versus lower two tertiles of HL domains 
are provided as online supplemental table S1. Patients 
with ESKD had better HL in the ‘social support domain’ 
(HLQ4) compared with patients with CKD (OR 0.41). 
Depression and education less than 12 years were associ-
ated with worse HL in seven and four out of nine domains, 
respectively.
Results of multivariable logistic regression, including 
all covariates that showed an association with any HL 
domain at a significance level of p<0.2 and ESKD versus 
CKD status as independent variables and HL category as 
the dependent variable, are given in table 5. We found 
that patients with ESKD had significantly better ‘social 
support’ HL (HLQ4, OR 0.36) after adjusting for covari-
ates. The association between depression and lower HL 
was significant for most HL domains (HLQ1–HLQ8) and 
approached significance for ‘understand health informa-
tion well enough to know what to do’ (HLQ9) domain 
(OR 2.26, p=0.051). Lower education was associated with 
lower ‘ability to find good health information’ (HLQ8, 
OR 2.60) and ‘understand health information well 
enough to know what to do’ (HLQ9, OR 2.50). Older age 
was associated with less ‘ability to actively manage health’ 
(HLQ3, OR 1.43) and ‘ability to find good health infor-
mation’ (HLQ8, OR 1.44). Not having a dedicated carer 
was significantly associated with lower HL pertaining to 
‘ability to actively manage health’ (HLQ3, OR 2.43) and 
‘appraisal of health information’ (HLQ 5, OR 2.86).
DISCUSSION
Our study shows that patients with ESKD on dialysis have 
better HL in domains relevant to ‘social support for 
health’ when compared with patients with CKD but not 
for other domains including ‘actively managing health’, 
or ‘ability to engage with healthcare providers’ despite 
regular and frequent interactions with health providers 
and health systems. These findings are counterintuitive 
and partly contradictory with existing literature.11 Our 
study also highlights the strong association between 
depression and most HL domains as well as the associ-
ation between education and HL domains relevant to 
processing health- related information.
According to the literature, the reported prevalence of 
limited HL varies from 8.4% to 49.6% in patients with 
ESKD and 16.3% to 63.3% in patients with non- dialysis 
CKD.8 The wide variation in the reported prevalence of 
HL may be due to the variations in the instruments used 
to measure HL, such as the Single- Item Literacy Screener 
(SILS), Brief Health Literacy Screener, Short- Test of 
Functional Health Literacy in Adults, Rapid Estimate of 
Adult Literacy in Medicine (REALM) and Newest Vital 
Sign.8 Although these commonly used instruments are 
validated and objective, they measure a very limited set of 
HL constructs.11 We used the more comprehensive and 
validated HLQ,9 which assesses the patient’s competency 
in several HL domains that are directly relevant to the 
interaction between the patient and chronic disease path-
ways.10 Though HLQ is a self- reported instrument and 
therefore subjective, it has been shown to have measure-
ment veracity at the patient and clinician levels12 and 
covers a greater breadth of the multidimensional concept 
of HL as defined by WHO1 compared with the objective 
HL tools.
Figure 1 Flow chart of patient participation in the study. 
CKD, chronic kidney disease; ESKD, end- stage kidney 
disease. *Ineligible patient (N=5) had dementia (2), intellectual 
important (1) or anticipated life expectancy <12 months due 
to terminal cancer (1) or severe heart failure (1). **Drop- outs 
included patients who, after entry into the study, withdrew 
consent (N=24), died (N=2) or had kidney transplantation 
(N=1) before full baseline data collection.
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Our observation of the strong independent association 
of depression with most HL domains highlights the impor-
tance of screening for depression in patients with kidney 
disease. Depression is highly prevalent in this population 
and associated with higher mortality and diminished 
quality of life.20 Lower HL based on HLQ tool has been 
shown to be significantly associated with depression in 
univariate models.11 A study using SILS to measure HL 
reported significant association between limited HL and 
depression in multivariate models adjusting for demo-
graphics, comorbidity and socioeconomic status in the 
incident dialysis cohort,21 while another study adjusting 
for age, gender, race, educational levels and other clinical 
variables found no association between depression and 
limited HL.22 In the latter study, HL was assessed using the 
REALM tool, which focuses on health- related vocabulary 
and reading comprehension and may not have captured 
HL domains important in healthcare delivery, such as 
the ability to appraise health information or engagement 
with healthcare providers.
We also noted significant associations between educa-
tional level and HL domains relevant to ‘ability to find 
Table 1 Baseline characteristics of the study population comparing patients with non- dialysis CKD and ESKD
Overall population Patients with CKD Patients with ESKD P value*
Patients (n) 223 114 109
Age (years)† 69.6 (62.8–74.3) 71.0 (65.9–74.6) 68.0 (59.0–74.0) 0.055
Gender (M/F) 61.4%/38.6% 61.4%/38.6% 61.5%/38.5% 0.992
Indigenous population 5.0% 2.6% 7.6% 0.095
Education (years)
  <12 53.1% 53.5% 52.8% 0.999
  12–13 8.1% 7.9% 8.3%
  13–15 12.2% 12.3% 12.0%
  ≥16 26.6% 26.3% 26.9%
Carer status (carer available) 26.0% 7.0% 45.9% <0.001
Gross annual income
  <$A25 000 57.9% 44.7% 71.6% 0.001
  $A25 000–$A50 000 29.2% 40.3% 17.4%
  $A50 000–$A75 000 7.2% 7.9% 6.4%
  >$A75 000 5.8% 7.0% 4.6%
Smoking status
  Current smoker 9.4% 7.0% 11.9% 0.095
  Former smoker 56.1% 61.4% 50.5%
  Non- smoker 34.5% 31.6% 37.6%
Cause of renal disease
  Diabetic nephropathy 33.9% 30.4% 37.6% 0.067
  Hypertension/vascular disease 20.8% 25.0% 16.5%
  Polycystic kidney disease 4.5% 2.7% 6.4%
  Glomerulonephritis 15.4% 11.6% 19.3%
  Others/unknown aetiology 25.3% 30.3% 20.2%
Comorbidity
  Diabetes 42.8% 38.9% 46.8% 0.237
  Hypertension 90.5% 88.5% 92.6% 0.299
  Ischaemic heart disease 38.0% 23.9% 52.8% <0.001
  Cerebrovascular disease 14.9% 11.5% 18.5% 0.144
  Peripheral vascular disease 21.7% 8.9% 35.2% <0.001
  Lung disease 27.6% 24.8% 30.6% 0.337
p values with a significance level <0.05 are shown in bold format.
*P value for difference estimated by Wilcoxon rank- sum test for continuous variables and by χ2 test for proportions.
†Median and IQR.
CKD, chronic kidney disease; ESKD, end- stage kidney disease; F, female; M, male.
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Table 2 Baseline cognitive and psychological measures of the study population comparing patients with non- dialysis CKD 
and ESKD
Overall population
(n=223)
Median (IQR)/%
Patients with 
CKD
(n=114)
Median (IQR)/%
Patients with 
ESKD
(n=109)
Median (IQR)/% P value*
Modified Mini- Mental State Examination (3MS) 
score†
94 (890–97) 95 (91–97) 93 (86–96) 0.001
Cognitive impairment (patients with 3MS score 
<85%)
17.6% 12.3% 23.2% 0.033
Trail- making test A (TMT- A) (s) 38 (29–52.5) 35 (28–45) 43.5 (33–68) <0.001
Trail- making test B (TMT- B) (s) 100 (73–143) 82 (65–117) 120 (83–201) <0.001
Difference between TMT- A and TMT- B (s) 62 (40–94) 46 (33–76) 72 (49–129) <0.001
Stroop interference score −2.5 (−7.2 to 2.8) −1.6 (−6.1 to 3.9) −3.6 (−8.2 to 1.4) 0.055
Beck Depression Inventory 2 (BDI-2) score 9 (4–14) 6.5 (3–11) 10 (5–17) <0.001
Depression (based on BDI-2 score of 14 or 
above)
26.9% 14.9% 39.5% <0.001
p values with a significance level <0.05 are shown in bold format.
*P value for difference estimated by Wilcoxon rank- sum test for continuous variables and χ2 test for difference in proportions.
†Median and IQR.
CKD, chronic kidney disease; ESKD, end- stage kidney disease.
Table 3 Comparison of mean HLQ scores between patients with CKD and ESKD
Domain and description
CKD population ESKD Population
P value*
Cohen’s 
d†Mean 95% CI Mean 95% CI
HLQ1
Feel understood and supported by 
healthcare providers
3.27 3.18 to 3.35 3.32 3.23 to 3.42 0.251 0.12
HLQ2
Have sufficient information to manage my 
health
2.98 2.90 to 3.06 3.10 3.00 to 3.20 0.061 0.26
HLQ3
Actively managing health
2.96 2.88 to 3.03 2.91 2.81 to 3.01 0.622 −0.10
HLQ4
Have social support for health
3.12 3.05 to 3.20 3.22 3.10 to 3.24 0.205 0.19
HLQ5
Appraise health information
2.72 2.62 to 2.80 2.77 2.65 to 2.88 0.916 0.09
HLQ6
Able to engage with healthcare providers
4.18 4.10 to 4.26 4.13 4.02 to 4.25 0.964 −0.09
HLQ7
Navigating healthcare system
4.08 3.99 to 4.17 4.02 3.90 to 4.13 0.613 0.12
HLQ8
Ability to find good health information
3.91 3.80 to 4.03 3.85 3.71 to 3.99 0.687 −0.09
HLQ9
Understand health information well enough 
to know what to do
4.14 4.04 to 4.23 4.04 3.91 to 4.16 0.488 −0.17
p values with a significance level <0.05 are shown in bold format
*P value for difference estimated by Wilcoxon rank- sum test for continuous variables and by χ2 test for proportions.
†Cohen’s d effect size for difference between scores of patients with ESKD and CKD.
CKD, chronic kidney disease; ESKD, end- stage kidney disease; HLQ, Health Literacy Questionnaire.
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good health information’ and ‘understanding health 
information enough to know what to do’. Education 
has been shown to be associated with HL in previous 
studies,22–24 which used the REALM tool to measure HL. 
However, higher HL measured by vocabulary- based tools 
like REALM was not associated with an increased uptake of 
self- care behaviours in CKD.25 Instruments like the HLQ 
that directly evaluate specific healthcare delivery- related 
domains may associate better with self- care behaviour, 
but this remains unproven and requires further research. 
The conceptually distinct nature of the HLQ domains11 
may explain why some domains are sensitive to education 
while others are not. We also noted that older subjects 
had lower HL domain scores for ‘active management of 
health’ and ‘finding good health information’. Multiple 
comorbidities which are frequent in older patients pose 
the biggest challenge to active self- management,26 27 but 
access to care and affordability also impact the older 
patients’ ability to self- manage their health, especially 
among culturally and linguistically diverse populations.27
Support from a family member or friend acting as a 
dedicated personal carer can be helpful in navigating 
the complex care pathways of multimorbidity, accessing 
and appraising health information, and chronic disease 
management, especially for the elderly and frail patients.27 
The Department of Social Services of the Australian 
Government provides a range of benefits, payments 
and concessions to eligible carers28 to encourage social 
support for patients suffering from chronic diseases. 
In our study, patients with ESKD receiving dialysis had 
significantly higher carer support than patients with 
CKD. Our finding of significant associations between 
‘not having a carer’ and lower HL for ‘actively managing 
health’ and ‘appraising health information’ may suggest a 
pathway for how lower social support leads to poor health 
outcomes. Discrepancy between expected and received 
social support has been shown to predict mortality in dial-
ysis patients.29
Patients with ESKD in our study did not have higher 
HL in ‘engagement with healthcare providers’, which is 
important in the context of frequent and regular inter-
action of dialysis patients with health providers and 
systems. Our findings are discrepant to the existing liter-
ature which reports better engagement HL in dialysis 
patients compared with general patient population.11 
Potential explanations for this discrepancy may be that 
we compared patients with ESKD with patients with CKD 
attending the same health service and adjusted for rele-
vant covariates, rather than using a historical control 
group of diverse patients used in the earlier study.11 
Patients’ capacity to improve their health outcomes can 
be limited by the lack of knowledge about the disease 
and its comorbidities, and by psychosocial influences 
and their inability to effectively interact and communi-
cate with healthcare providers.30 Patient engagement and 
patient activation are integral to the effective delivery 
Table 4 Proportion of patients in ‘higher’ (compared with ‘lower’ two tertiles) health literacy tertile in CKD and ESKD groups
Domain and description
CKD population Dialysis population
P value*n % n %
HLQ1
Feel understood and supported by healthcare 
providers
26 23.0 31 29.5 0.274
HLQ2
Have sufficient information to manage my health
30 26.6 38 36.5 0.113
HLQ3
Actively managing health
28 24.8 35 33.3 0.164
HLQ4
Have social support for health
22 19.5 39 37.1 0.004
HLQ5
Appraise health information
17 15.0 24 22.9 0.140
HLQ6
Able to engage with healthcare providers
33 29.2 39 37.1 0.213
HLQ7
Navigating healthcare system
32 28.3 30 28.9 0.932
HLQ8
Ability to find good health information
33 29.2 29 27.9 0.830
HLQ9
Understand health information well enough to 
know what to do
36 31.9 34 32.7 0.896
p values with a significance level <0.05 are shown in bold format.
*P value for difference estimated by Wilcoxon rank- sum test for continuous variables and by χ2 test for proportions.
CKD, chronic kidney disease; ESKD, end- stage kidney disease; HLQ, Health Literacy Questionnaire.
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of patient- centred care. Improved treatment adherence 
has been associated with better patient engagement and 
activation.31 However, it is unclear whether patient- level 
interventions to enhance these attributes will improve 
clinical outcomes and requires further research. An 
integrated approach to address limited HL and support 
self- management in chronic diseases should engage 
different stakeholders, including patients, health profes-
sionals, healthcare managers, community organisations 
and policymakers.32 A systematic review on the effective-
ness of patient- level HL interventions reported that most 
interventions focused on the functional level of HL or 
numeracy, but the marked heterogeneity in study designs, 
HL tools and outcome measures compromises the quality 
of evidence.33 On the other hand, health policy initiatives 
like ‘Universal precaution toolkits’ help address limited 
HL by recommending changes to simplify communica-
tion and reduce the complexity of healthcare for patients 
of all HL levels, since the providers may not be able to 
identify which patients have difficulty in understanding 
health- related information.34 Thus, diverse strategies 
involving multiple stakeholders are needed to address 
limited HL.32
To our knowledge, this is the first direct comparison of 
HL profile of patients with ESKD and CKD using a multi-
domain HL instrument in a robust multivariable model 
accounting for the relevant confounders. However, our 
study has several limitations. Selection bias may have 
occurred in our study because we used a cross- sectional 
design and almost 30% of the target population declined 
to participate or dropped out before the baseline data 
collection. Our sample size is modest and comprised 
patients attending renal outpatient clinics or dialysis units 
in a single health district. A much larger sample from 
multiple geographical locations would have provided a 
more confident estimate of the relationships between HL 
markers and included covariates. However, our use of the 
comparison group consisting of patients with CKD from 
the same sociodemographic and geographical cohort 
provided an opportunity for a more robust comparison 
between patients with CKD and ESKD after adjusting for 
confounders. Furthermore, the sensitivity and specificity 
of instruments used to measure cognitive and psycho-
logical measures would have an effect on the reliability 
of the reported findings. A more robust battery of tests 
administered by a psychologist may have enabled us to 
classify cognitive impairment and depression with greater 
precision, refining the estimate of their association with 
HL, but such an approach would have limited wider 
applicability for clinical practice. In our study, the test 
instruments were administered by research coordinators 
who were nurses, which is more practical and feasible in a 
routine clinical setting.
In conclusion, our study highlights the significant associ-
ation between depression and nearly all the HL domains, 
while advanced age, educational level and carer support 
affected specific HL domains. Patients with ESKD on dial-
ysis did not have improved engagement with providers C
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Open access 
compared with patients with CKD after adjusting for 
other relevant covariates but had improved social support 
markers, even after adjusting for the presence of a carer. 
Though the impact of HL interventions in improving 
the HL metrics is unclear, strategies to address depres-
sion, patient–provider engagement and self- management 
support strategies may help improve health outcomes for 
patients with ESKD and CKD.
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